Search Ontology:
ChEBI
N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2
- Term ID
- CHEBI:138409
- Synonyms
-
- cmpd21
- compound 21
- N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-1H-pyrazol-5-yl]carbonyl}glycyl-D-arginylglycyl-D-alpha-aspartyl-D-alpha-aspartyl-D-alpha-asparagine
- N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-GdRGdDdDdD-NH2
- N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-Gly-D-Arg-Gly-D-alpha-Asp-D-alpha-Asp-D-alpha-Asp-NH2
- Definition
- A hexapeptide consisting of N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-1H-pyrazol-5-yl]carbonyl}glycine, D-arginine, glycine, D-alpha-aspartic acid, D-alpha-aspartic acid, and D-alpha-aspartic 1-amide residues coupled in sequence. An angiotensin II type 2 receptor agonist.
- References
-
- PMID:22184324
- PMID:22802221
- PMID:23164706
- PMID:24041944
- PMID:24329698
- PMID:24361310
- PMID:24508710
- PMID:24687998
- PMID:24752645
- PMID:24914880
- PMID:25186297
- PMID:25304472
- PMID:25398877
- PMID:25560767
- PMID:25753301
- PMID:25776077
- PMID:26783414
- PMID:27168137
- PMID:28099262
- PMID:28192099
- PMID:28456626
- PMID:28711702
- Reaxys:25999889
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
Show first 5 Terms
Phenotype
Phenotype resulting from N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2
Phenotype where environments contain N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2
Phenotype modified by environments containing N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2
Human Disease Model